.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Fuji
Chinese Patent Office
Daiichi Sankyo
Boehringer Ingelheim
UBS
Merck
Medtronic
Teva

Generated: September 19, 2017

DrugPatentWatch Database Preview

Mikart Company Profile

« Back to Dashboard

What is the competitive landscape for MIKART, and what generic and branded alternatives to MIKART drugs are available?

MIKART has sixty-three approved drugs.



Summary for Applicant: Mikart

Patents:0
Tradenames:24
Ingredients:22
NDAs:63
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mikart
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
SOLUTION;ORAL089557-001Apr 29, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Mikart
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
SOLUTION;ORAL081226-001Oct 27, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Mikart
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
TABLET;ORAL040658-001Jan 19, 2006AARXNoYes► Subscribe► Subscribe► Subscribe
Mikart
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL090533-004Oct 25, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
Mikart
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
acetaminophen; hydrocodone bitartrate
CAPSULE;ORAL089008-001Feb 21, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Mikart
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL090533-007Oct 25, 2011RXNoNo► Subscribe► Subscribe► Subscribe
Mikart
DEXTROAMPHETAMINE SULFATE
dextroamphetamine sulfate
TABLET;ORAL090533-002Oct 25, 2011AARXNoNo► Subscribe► Subscribe► Subscribe
Mikart
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE
acetaminophen; butalbital; caffeine
SOLUTION;ORAL040387-001Jan 31, 2003RXNoYes► Subscribe► Subscribe► Subscribe
Mikart
BENZONATATE
benzonatate
CAPSULE;ORAL040851-001Nov 9, 2009AARXNoNo► Subscribe► Subscribe► Subscribe
Mikart
BUTAPAP
acetaminophen; butalbital
TABLET;ORAL089988-001Oct 26, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
McKinsey
Fuji
Mallinckrodt
McKesson
Medtronic
Argus Health
Colorcon
Deloitte
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot